Other languages Applied DNA Sciences, Inc.

Equities

APDN

US03815U3005

Market Closed - Nasdaq Other stock markets 04:30:00 2024-04-19 pm EDT			5-day change	1st Jan Change
0.3431 ^USD	+1.63%		-9.42%	-44.37%

Apr. 03	Certain Warrants of Applied DNA Sciences, Inc. are subject to a Lock-Up Agreement Ending on 3-APR-2024.	CI
Apr. 03	Certain Options of Applied DNA Sciences, Inc. are subject to a Lock-Up Agreement Ending on 3-APR-2024.	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Applied DNA Sciences, Inc. to Showcase Linea DNA and Linea IVT Platforms At 24Th Annual World Vaccine Congress	Mar. 14
Applied DNA Sciences Files Prospectus for Potential Secondary Stock Offerings	Mar. 12
Applied DNA Sciences, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023	Feb. 08
Applied DNA Sciences, Inc. Announces Joint Development Agreement to Integrate Linea IVT Platform into CDMO Kudo Biotechnology?s mRNA Manufacturing Workflow	Dec. 14
Applied DNA Sciences, Inc. Reports Earnings Results for the Fourth Quarter Ended September 30, 2023	Dec. 07
Applied DNA Sciences, Inc. Reports Earnings Results for the Full Year Ended September 30, 2023	Dec. 07
Applied DNA Sciences, Inc. Announces Receipt of Linea(TM) DNA Follow-On Order for Cancer Diagnostic Application	Nov. 28
Applied DNA Sciences, Inc. Extends Application of Linea(Tm) Ivt Platform to Sna (Self-Amplifying Mrna)	Nov. 16
Applied DNA Sciences, Inc. Advances Commercialization of Linea(TM) IVT Platform	23-09-06
Applied DNA Sciences, Inc. Announces Appointment of Beverly Wolgast as Executive Director of Quality and cGMP Programs	23-09-06
Applied DNA Sciences, Inc. Announces Availability and First Customer Shipment of New Linea(TM) IVT Evaluation Kit	23-08-29
Applied DNA Sciences Files Patent Applications for mRNA Production by Reducing Double-Stranded RNA	23-08-23
Applied DNA Sciences, Inc. Files Provisional Patent Applications for Methods of Double-Stranded RNA Mitigation in Next-Generation mRNA Production	23-08-23
Applied DNA Sciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2023	23-08-10
Applied Dna Sciences, Inc. Announces That Scott L. Anchin Will Not Stand for Re-Election as Director	23-08-01
Top Midday Gainers	23-07-13
Applied DNA Sciences, Inc. acquired Spindle Biotech Inc. for $2.8 million.	23-07-12
Applied DNA Sciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2023	23-05-11
Applied DNA Sciences, Inc. Achieves Milestone for Large-Scale LinearDNA™ Production, Delivers Largest Single Shipment by Volume to Date	23-03-29
Applied DNA Clinical Labs, LLC Submits Validation Package to New York State Department of Health for Approval of Pharmacogenomic Assay	23-03-22

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Applied DNA Sciences, Inc.

Equities

APDN

US03815U3005

Other languages

Filters